Unlock AI-driven, actionable R&D insights for your next breakthrough.

L-Methionine As A Methyl Donor: Biochemical Mechanisms, Enzymatic Pathways, And Industrial Production Strategies

NOV 17, 202664 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
L-Methionine serves as a critical methyl donor in biological systems through its conversion to S-adenosyl-L-methionine (SAM), the principal methyl group donor in cellular metabolism. This essential amino acid participates in transmethylation reactions affecting neurotransmitter synthesis, lipid metabolism, DNA methylation, and epigenetic regulation. Beyond its physiological role as a methyl donor, L-Methionine functions as a sulfur donor and precursor for cysteine, taurine, and other sulfur-containing biomolecules 2,5. Understanding L-Methionine's dual role as both methyl and sulfur donor is essential for optimizing its production via fermentation and enzymatic bioconversion, as well as for designing therapeutic interventions targeting methylation capacity enhancement.
Want to know more material grades? Try Patsnap Eureka Material.

Biochemical Role Of L-Methionine As A Methyl Donor In Cellular Metabolism

L-Methionine occupies a central position in one-carbon metabolism as the immediate precursor of S-adenosyl-L-methionine (SAM), which is synthesized through the action of S-adenosyltransferase (also known as methionine adenosyltransferase) in an ATP-dependent reaction 2,5. SAM functions as the universal methyl donor in over 100 different methyltransferase reactions, donating its methyl group to DNA, RNA, proteins, lipids, and small molecules 3. Following methyl group transfer, SAM is converted to S-adenosylhomocysteine (SAH), which is subsequently hydrolyzed to homocysteine and adenosine. Homocysteine can be remethylated back to L-Methionine through two distinct pathways: a cobalamin-dependent pathway catalyzed by methionine synthase (encoded by metH) and a cobalamin-independent pathway catalyzed by methionine synthase (encoded by metE) 12. This regeneration cycle is critical for maintaining cellular methylation capacity.

The efficiency of L-Methionine as a methyl donor depends on several cofactors and regulatory mechanisms. Magnesium ions serve as essential cofactors for S-adenosyltransferase activity, with optimal ratios of magnesium compounds to L-Methionine ranging from 1:2 to 1:6 by mass 5,13. Folic acid and its derivatives participate in the remethylation of homocysteine, thereby supporting the regeneration of L-Methionine from the methylation cycle 5,13. Vitamin B12 (cobalamin) is required for the metH-encoded methionine synthase, while vitamin B6 (pyridoxal phosphate) serves as a cofactor for cystathionine β-synthase in the transsulfuration pathway 5,13. The interplay between these cofactors determines the overall methylation capacity and the balance between transmethylation and transsulfuration pathways.

SAM-dependent methylation reactions have profound physiological consequences. In the central nervous system, SAM serves as a methyl donor for the synthesis of neurotransmitters including dopamine, serotonin, and norepinephrine, explaining L-Methionine's role in mood regulation and its potential antidepressant effects 2,3. In hepatic metabolism, SAM and L-Methionine prevent lipid accumulation in the liver and arteries by promoting phosphatidylcholine synthesis and very-low-density lipoprotein (VLDL) secretion 2. DNA methylation, mediated by SAM-dependent DNA methyltransferases, regulates gene expression and epigenetic inheritance 3. Protein methylation affects signal transduction, chromatin structure, and protein-protein interactions 3. The methylation of phospholipids influences membrane fluidity and cellular signaling 3.

Enzymatic Pathways For L-Methionine Biosynthesis And Methyl Group Transfer

Direct Sulfhydrylation Pathway Using O-Acylhomoserine Substrates

The biosynthesis of L-Methionine in microorganisms proceeds through multiple enzymatic routes, with the direct sulfhydrylation pathway representing one of the most efficient approaches for industrial production. In this pathway, O-acetyl-L-homoserine or O-succinyl-L-homoserine serves as the immediate precursor, reacting with reduced sulfur compounds (methyl mercaptan or hydrogen sulfide) to form L-Methionine 1,4,7,11. The enzyme O-acetylhomoserine sulfhydrylase (encoded by genes such as metY or metZ) catalyzes the direct incorporation of the methylthio group from methyl mercaptan (CH₃SH) into O-acetyl-L-homoserine, yielding L-Methionine and acetate as products 4,6,9,10. Similarly, O-succinylhomoserine sulfhydrylase catalyzes the analogous reaction with O-succinyl-L-homoserine, producing L-Methionine and succinate 2,7.

The metZ gene has emerged as a particularly promising candidate for enhancing L-Methionine production in recombinant microorganisms. Recent studies demonstrate that introduction of a foreign metZ gene into L-Methionine-producing strains significantly increases yield compared to strains relying on metY or metB genes 6,9,10. The metZ-encoded enzyme exhibits several advantages: reduced feedback inhibition by L-Methionine, lower by-product formation compared to the transsulfuration pathway (metB), and higher specific activity toward O-acetyl-L-homoserine 6,9,10. In Corynebacterium species engineered with heterologous metZ genes, L-Methionine titers increased by 30-50% relative to control strains, with concurrent reduction in cystathionine and other sulfur-containing by-products 6,9,10.

The direct sulfhydrylation pathway offers significant advantages for industrial L-Methionine production by circumventing the energy-intensive reduction of inorganic sulfate. Whereas complete fermentation from aspartate and sulfate requires 3 ATP, 1 GTP, and 6 NADPH molecules per L-Methionine molecule, the use of pre-reduced sulfur in the form of methyl mercaptan reduces the energy demand to 1 ATP and 2 NADPH 7. This energy savings translates to higher theoretical yields and reduced nutrient consumption. However, the direct sulfhydrylation approach requires careful control of methyl mercaptan partial pressure in the reaction vessel, with optimal ranges between 10 kPa and 180 kPa at reaction temperature to balance substrate availability against toxicity to enzymes and cells 12.

Transsulfuration Pathway And Alternative Biosynthetic Routes

An alternative biosynthetic route to L-Methionine involves the transsulfuration pathway, in which O-acylhomoserine reacts with cysteine rather than with reduced sulfur compounds. The enzyme cystathionine γ-synthase (encoded by metB) catalyzes the condensation of O-succinyl-L-homoserine or O-acetyl-L-homoserine with cysteine to form cystathionine, which is subsequently cleaved by cystathionine β-lyase (encoded by metC) to yield L-homocysteine, pyruvate, and ammonia 2,9,12. L-Homocysteine is then methylated by methionine synthase (metE or metH) to produce L-Methionine 12. While this pathway is naturally present in many microorganisms, it suffers from several limitations for industrial application: the metB-encoded enzyme produces significant quantities of by-products including homoserine and α-ketobutyrate; cystathionine γ-synthase is subject to feedback inhibition by L-Methionine and SAM; and the pathway requires cysteine as a substrate, adding to production costs 2,6,9.

The complete biosynthetic pathway from aspartate to L-Methionine involves multiple enzymatic steps beyond the final sulfur incorporation. Aspartate is first phosphorylated by aspartate kinase and reduced by aspartate-semialdehyde dehydrogenase to aspartate-semialdehyde, which is then converted to L-homoserine by homoserine dehydrogenase 12. L-Homoserine is subsequently acylated by homoserine O-acetyltransferase (encoded by metA or metX) to form O-acetyl-L-homoserine, or by homoserine O-succinyltransferase to form O-succinyl-L-homoserine 1,11,12. The choice of acyl group (acetyl vs. succinyl) affects downstream processing: O-acetyl-L-homoserine is generally preferred for enzymatic conversion because the acetate by-product is more easily metabolized or removed than succinate 7.

Recent advances in metabolic engineering have focused on optimizing the entire pathway from glucose to L-Methionine by overexpressing rate-limiting enzymes, removing feedback inhibition, and eliminating competing pathways. Key strategies include: deregulation of aspartate kinase to relieve feedback inhibition by L-Methionine and lysine; overexpression of homoserine dehydrogenase and homoserine O-acetyltransferase to increase O-acetyl-L-homoserine pools; deletion or downregulation of threonine synthase to prevent diversion of homoserine to threonine; and introduction of heterologous metZ genes with superior kinetic properties 6,9,10. These combined modifications have enabled production strains to achieve L-Methionine titers exceeding 40 g/L in fed-batch fermentation 2.

Industrial Production Methods For L-Methionine: Chemical Synthesis Versus Biotechnological Approaches

Chemical Synthesis Routes And Stereochemical Limitations

Industrial-scale chemical synthesis of methionine predominantly employs the Bucherer-Bergs reaction, a variant of the Strecker synthesis, in which methylmercaptopropionaldehyde (prepared from acrolein and methyl mercaptan), hydrogen cyanide, ammonia, and carbon dioxide react to form 5-(β-methylmercaptoethyl)hydantoin (methionine hydantoin) 2,9,11. This intermediate is subsequently hydrolyzed under alkaline conditions to yield the alkali metal salt of methionine, which is then neutralized with acid to liberate free methionine 11. Alternative chemical routes include amidocarbonylation reactions and various modifications of the Strecker synthesis 11. While these chemical processes are well-established and economically competitive, they suffer from a fundamental limitation: they produce racemic mixtures containing equal amounts of D-methionine and L-Methionine 1,2,4,9,11.

The presence of D-methionine in chemically synthesized products poses challenges for pharmaceutical and nutraceutical applications, which require enantiomerically pure L-Methionine 1,5. Although D-methionine can be utilized by animals through enzymatic racemization, this conversion is inefficient in monogastric species and humans 2. Separation of the D,L-racemate into pure enantiomers can be achieved through enzymatic resolution, chromatographic methods, or preferential crystallization, but these additional steps increase production costs and generate waste streams 1,5. Furthermore, chemical synthesis relies on petrochemical-derived starting materials (acrolein, methyl mercaptan from methanol and hydrogen sulfide), raising concerns about sustainability and environmental impact 1.

Two-Step Biotechnological Process: Fermentation Plus Enzymatic Conversion

To overcome the limitations of chemical synthesis, a two-step biotechnological process has been developed that combines fermentative production of L-Methionine precursors with enzymatic conversion to L-Methionine 1,2,7,11. In the first step, genetically engineered microorganisms (typically Escherichia coli or Corynebacterium glutamicum strains) are cultured under conditions that promote accumulation of O-acetyl-L-homoserine or O-succinyl-L-homoserine in the culture broth 1,2,7. These strains are constructed by overexpressing the biosynthetic genes for homoserine and O-acylhomoserine production while deleting or attenuating the genes for downstream L-Methionine synthesis (metY, metZ, metB) to prevent premature conversion of the precursor 2,7. Fermentation is typically conducted in fed-batch mode with glucose as the carbon source, achieving O-acylhomoserine concentrations of 20-60 g/L 2.

In the second step, the accumulated O-acylhomoserine is enzymatically converted to L-Methionine by reaction with methyl mercaptan in the presence of purified or partially purified O-acetylhomoserine sulfhydrylase or O-succinylhomoserine sulfhydrylase 1,2,4,7,11. The enzyme can be supplied as a cell-free extract, immobilized enzyme preparation, or whole-cell biocatalyst expressing high levels of the sulfhydrylase 1,4,11. Reaction conditions are optimized to maintain methyl mercaptan partial pressure between 10 kPa and 180 kPa, with reaction temperatures typically between 25°C and 40°C and pH between 7.0 and 8.5 12. Under these conditions, conversion efficiencies exceeding 95% can be achieved within 2-6 hours 1,4,12. The resulting L-Methionine is recovered by crystallization, ion-exchange chromatography, or other purification methods 1.

The two-step process offers several advantages over complete fermentation: it circumvents feedback inhibition of L-Methionine biosynthesis by separating precursor accumulation from final product formation; it reduces the toxic effects of reduced sulfur compounds on the production strain by adding methyl mercaptan only during the enzymatic conversion step; it enables the use of optimized conditions for each step independently; and it produces exclusively L-Methionine without the D-enantiomer 1,2,7. However, the process also generates stoichiometric amounts of acetate or succinate as by-products, which must be removed during downstream processing 7. Recent innovations have focused on reducing by-product formation through the use of alternative substrates or enzymatic cascades 7.

Direct Fermentation And Emerging Hybrid Approaches

Complete fermentation of L-Methionine from glucose and inorganic sulfate represents an alternative biotechnological approach that eliminates the need for separate enzymatic conversion steps 1,2. In this approach, production strains are engineered to overexpress the entire biosynthetic pathway from aspartate to L-Methionine, including sulfate reduction and assimilation pathways 1. Key genetic modifications include: amplification of sulfate transporters and ATP sulfurylase to increase sulfate uptake and activation; overexpression of sulfite reductase and the cysteine biosynthetic pathway to generate reduced sulfur; deregulation of feedback-sensitive enzymes (aspartate kinase, homoserine dehydrogenase, methionine synthase); and deletion of competing pathways (threonine biosynthesis, lysine biosynthesis) 2. Advanced strains incorporating these modifications can produce L-Methionine at titers of 10-25 g/L in fed-batch fermentation 2.

The primary challenge in direct fermentation is the high energy cost of sulfate reduction, which requires 2 ATP, 1 GTP, and 4 NADPH molecules per sulfur atom incorporated into L-Methionine 7. This energy demand significantly reduces the theoretical yield of L-Methionine from glucose and necessitates higher nutrient consumption compared to the two-step process 7. Additionally, the accumulation of L-Methionine in the fermentation broth exerts feedback inhibition on multiple biosynthetic enzymes, limiting final titers 2. Strategies to overcome these limitations include: dynamic regulation of pathway genes using biosensors to relieve feedback inhibition only when L-Methionine concentrations are high; in situ product removal using adsorbent resins or membrane extraction to maintain low intracellular L-Methionine levels; and supplementation of the fermentation medium with intermediate sulfur compounds (thiosulfate, cysteine) to reduce the energy burden of sulfate reduction 2.

Emerging hybrid approaches combine elements of chemical synthesis, fermentation, and enzymatic conversion to optimize overall process economics and sustainability. One promising strategy involves the enzymatic production of methyl mercaptan from dimethyl disulfide (DMDS) through enzymatic hydrogenolysis, followed by reaction with fermentatively produced O-acetyl-L

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
ARKEMA FRANCEPharmaceutical and nutraceutical applications requiring enantiomerically pure L-methionine as methyl donor for SAM synthesis, neurotransmitter production, and methylation capacity enhancement in therapeutic interventions.Enzymatic L-Methionine Production SystemTwo-step biotechnological process combining fermentation of O-acetyl-L-homoserine precursor with enzymatic conversion using metZ-encoded sulfhydrylase, producing exclusively L-enantiomer methionine with conversion efficiency exceeding 95% within 2-6 hours, eliminating D-methionine contamination from chemical synthesis.
CJ CheilJedang CorporationIndustrial-scale production of L-methionine for feed additives, food supplements, and pharmaceutical raw materials where high methylation capacity and sulfur donor function are required.MetZ-Enhanced Fermentation PlatformIntroduction of foreign metZ gene into L-methionine-producing strains increases yield by 30-50% compared to metY or metB-based strains, with reduced feedback inhibition and lower by-product formation, achieving titers exceeding 40 g/L in fed-batch fermentation.
Evonik Operations GmbHCost-effective production of L-methionine as methyl donor precursor for SAM-dependent methylation reactions in lipid metabolism, DNA methylation, and neurotransmitter synthesis applications.Direct Sulfhydrylation BioprocessO-acetylhomoserine sulfhydrylase-catalyzed direct incorporation of methylthio group from methyl mercaptan reduces energy demand to 1 ATP and 2 NADPH per L-methionine molecule (versus 3 ATP, 1 GTP, 6 NADPH for complete fermentation), improving theoretical yield and reducing nutrient consumption.
DE LUCA MARIANutraceutical and pharmaceutical formulations for enhancing cellular methylation capacity, antidepressant therapy, epigenetic regulation, and prevention of lipid accumulation in liver and arteries.SAM-Phytate Complex FormulationSalts or complexes of S-adenosyl-L-methionine (derived from L-methionine) with phytic acid demonstrate enhanced storage stability and synergistic biological activity, combining methyl donor function with antioxidant and mood-stabilizing effects of inositol metabolites.
BISSBORT SIEGBERT HEINRICHClinical treatment of methylation deficiency conditions affecting neurotransmitter synthesis, phosphatidylcholine production, DNA methylation, and prevention of homocysteine accumulation in cardiovascular and neurological disorders.L-Methionine Methylation Enhancement TherapyFormulation containing L-methionine with magnesium compounds (1:2 to 1:6 ratio), folic acid, and B-vitamins optimizes conversion to SAM and homocysteine remethylation, enhancing overall methylation capacity at dosage of 20-90mg per kg body mass per day.
Reference
  • Method for producing l-methionine
    PatentActiveSG11201802624YA
    View detail
  • Method for increasing methionine productivity using a mixture of methyl mercaptan and dimethyl sulfide
    PatentActiveDK2402453T3
    View detail
  • Salts or Complexes of Methyl Donors With Phytic Acid or Its Derivatives and Method for the Synthesis Thereof
    PatentActiveUS20090175914A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png